Exploring the Cardio-Protective Effect of Bioactive Compounds Present in Ginger, Garlic, and Turmeric
DOI:
https://doi.org/10.61919/jhrr.v4i1.699Keywords:
Cardiovascular Diseases, ginger, garlic, turmeric, bioactive compounds, lipid profile, Anti-inflammatory, antioxidantAbstract
Background: Cardiovascular diseases (CVDs) are the leading cause of mortality globally, with lifestyle and dietary habits playing crucial roles in their development and progression. Spices such as ginger, garlic, and turmeric have been traditionally recognized for their health benefits, attributed to their rich content of bioactive compounds. These spices offer potential therapeutic strategies for managing and preventing CVDs through various mechanisms, including anti-inflammatory, antioxidant, hypo-lipidemic, and anti-thrombotic properties.
Objective: This review aims to synthesize current evidence on the cardioprotective effects of ginger, garlic, and turmeric, focusing on their impact on lipid profiles, endothelial function, and overall cardiovascular risk factors.
Methods: A comprehensive search of databases such as PubMed, Scopus, and Web of Science was conducted to identify relevant studies published up to 2023. Criteria for inclusion encompassed clinical trials and observational studies examining the effects of ginger, garlic, and turmeric on CVD risk factors. Data on study design, population, intervention, outcomes, and conclusions were extracted and synthesized.
Results: The review included studies that reported beneficial effects of ginger, garlic, and turmeric on cardiovascular health. Specifically, these spices were found to improve lipid profiles by reducing levels of total cholesterol, low-density lipoprotein (LDL), and triglycerides, while increasing high-density lipoprotein (HDL). Furthermore, they exhibited anti-inflammatory and antioxidant activities, which are vital in mitigating endothelial dysfunction and reducing cardiovascular risk.
Conclusion: Ginger, garlic, and turmeric possess significant potential in reducing CVD risk through multiple mechanisms. Their inclusion in the diet may offer a natural and complementary approach to conventional CVD therapies. However, further large-scale, randomized controlled trials are necessary to confirm these findings and facilitate the integration of these spices into medical practice for CVD prevention and management.
Downloads
References
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018 Mar 20;137(12):e67-492.
Anand SS, Hawkes C, De Souza RJ, Mente A, Dehghan M, Nugent R, et al. Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the workshop convened by the World Heart Federation. J Am Coll Cardiol. 2015 Oct 6;66(14):1590-614.
Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation. 2010 Jul 27;122(4):406-41.
Shaito A, Thuan DT, Phu HT, Nguyen TH, Hasan H, Halabi S, et al. Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety. Front Pharmacol. 2020 Apr 7;11:509974.
Pourmasoumi M, Hadi A, Rafie N, Najafgholizadeh A, Mohammadi H, Rouhani MH. The effect of ginger supplementation on lipid profile: A systematic review and meta-analysis of clinical trials. Phytomedicine. 2018 Apr 1;43:28-36.
Kulczyński B, Gramza-Michałowska A. The importance of selected spices in cardiovascular diseases. Adv Hyg Exp Med. 2016 Nov 14;70:1131-41.
Madkor HR, Mansour SW, Ramadan G. Modulatory effects of garlic, ginger, turmeric and their mixture on hyperglycaemia, dyslipidaemia and oxidative stress in streptozotocin–nicotinamide diabetic rats. Br J Nutr. 2011 Apr;105(8):1210-7.
Bode AM, Dong Z. The amazing and mighty ginger. In: Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. 2011.
Roudsari NM, Lashgari NA, Momtaz S, Roufogalis B, Abdolghaffari AH, Sahebkar A. Ginger: A complementary approach for management of cardiovascular diseases. Biofactors. 2021 Nov;47(6):933-51.
Stoner GD. Ginger: is it ready for prime time?. Cancer Prev Res. 2013 Apr 1;6(4):257-62.
Mao QQ, Xu XY, Cao SY, Gan RY, Corke H, Beta T, et al. Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods. 2019 May 30;8(6):185.
Morvaridzadeh M, Fazelian S, Agah S, Khazdouz M, Rahimlou M, Agh F, et al. Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Cytokine. 2020 Nov 1;135:155224.
Arablou T, Aryaeian N, Valizadeh M, Hosseini A, Djalali M. The effect of ginger consumption on some cardiovascular risk factors in patients with type 2 diabetes mellitus.
Ahmed SM, Luo L, Namani A, Wang XJ, Tang X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis. 2017 Feb 1;1863(2):585-97.
Morvaridzadeh M, Fazelian S, Agah S, Khazdouz M, Rahimlou M, Agh F, et al. Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Cytokine. 2020 Nov 1;135:155224.
Salaramoli S, Mehri S, Yarmohammadi F, Hashemy SI, Hosseinzadeh H. The effects of ginger and its constituents in the prevention of metabolic syndrome: A review. Iran J Basic Med Sci. 2022 Jun;25(6):664.
Bhandari U, Pillai KK. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol. 2005 Feb 28;97(2):227-30.
ElRokh ES, Yassin NA, El-Shenawy SM, Ibrahim BM. Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacology. 2010 Dec;18:309-15.
Mazidi M, Gao HK, Rezaie P, Ferns GA. The effect of ginger supplementation on serum C-reactive protein, lipid profile and glycaemia: a systematic review and meta-analysis. Food Nutr Res. 2016 Jan 1;60(1):32613.
Mohd Yusof YA. Gingerol and its role in chronic diseases. In: Drug discovery from mother nature. 2016:177-207.
Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels. Saudi Med J. 2008;29(9):1280-4.
Duhamel TA, Xu YJ, Arneja AS, Dhalla NS. Targeting platelets for prevention and treatment of cardiovascular disease. Expert Opin Ther Targets. 2007 Dec 1;11(12):1523-33.
Londhe VP, Gavasane AT, Nipate SS, Bandawane DD, Chaudhari PD. Role of garlic (Allium sativum) in various diseases: An overview. J Angiogenes Res. 2011;12(13):129-34.
Tattelman E. Health effects of garlic. Am Fam Physician. 2005 Jul 1;72(01):103-6.
Shang A, Cao SY, Xu XY, Gan RY, Tang GY, Corke H, et al. Bioactive compounds and biological functions of garlic (Allium sativum L.). Foods. 2019 Jul 5;8(7):246.
Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T. Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2008 Dec;8:1-2.
Ried K, Frank OR, Stocks NP. Aged garlic extract reduces blood pressure in hypertensives: a dose–response trial. Eur J Clin Nutr. 2013 Jan;67(1):64-70.
Siegel G, Walter A, Engel S, Walper A, Michel F. Pleiotropic effects of garlic. Wien Med Wochenschr. 1999 Jan 1;149(8-10):217-24.
Karagodin VP, Sobenin IA, Orekhov AN. Antiatherosclerotic and cardioprotective effects of time-released garlic powder pills. Curr Pharm Des. 2016 Jan 1;22(2):196-213.
Asdaq SM. Antioxidant and hypolipidemic potential of aged garlic extract and its constituent, s-allyl cysteine, in rats. Evid Based Complement Alternat Med. 2015 Oct;2015.
Sobenin IA, Myasoedova VA, Iltchuk MI, Zhang DW, Orekhov AN. Therapeutic effects of garlic in cardiovascular atherosclerotic disease. Chin J Nat Med. 2019 Oct 1;17(10):721-8.
Orekhov AN, Oishi Y, Nikiforov NG, Zhelankin AV, Dubrovsky L, Sobenin IA, et al. Modified LDL particles activate inflammatory pathways in monocyte-derived macrophages: transcriptome analysis. Curr Pharm Des. 2018 Jul 1;24(26):3143-51.
Lee DY, Li H, Lim HJ, Lee HJ, Jeon R, Ryu JH. Anti-inflammatory activity of sulfur-containing compounds from garlic. J Med Food. 2012 Nov 1;15(11):992-9.
Rodrigues C, Percival SS. Immunomodulatory effects of glutathione, garlic derivatives, and hydrogen sulfide. Nutrients. 2019 Jan 30;11(2):295.
Zamani Taghizadeh Rabe S, Ghazanfari T, Siadat Z, Rastin M, Zamani Taghizadeh Rabe S, Mahmoudi M. Anti-inflammatory effect of garlic 14-kDa protein on LPS-stimulated-J774A.1 macrophages. Immunopharmacol Immunotoxicol. 2015 Mar 4;37(2):158-64.
Kiesewetter H, Jung F, Pindur G, Jung EM, Mrowietz C, Wenzel E. Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int J Clin Pharmacol Ther Toxicol. 1991 Apr 1;29(4):151-5.
Rahman K. Effects of garlic on platelet biochemistry and physiology. Mol Nutr Food Res. 2007 Nov;51(11):1335-44.
Verma RK, Kumari P, Maurya RK, Kumar V, Verma RB, Singh RK. Medicinal properties of turmeric (Curcuma longa L.): A review. Int J Chem Stud. 2018;6(4):1354-7.
Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Multitargeting by turmeric, the golden spice: From kitchen to clinic. Mol Nutr Food Res. 2013 Sep;57(9):1510-28.
Heath DD, Khwaja F, Rock CL. Curcumin content of turmeric and curry powders. FASEB J. 2004 Mar 23;18(4):A125.
Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 1997 Aug 1;15(12):1867-76.
Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors. 2013 Jan;39(1):69-77.
Cox FF, Misiou A, Vierkant A, Ale-Agha N, Grandoch M, Haendeler J, Altschmied J. Protective effects of curcumin in cardiovascular diseases—Impact on oxidative stress and mitochondria. Cells. 2022 Jan 20;11(3):342.
Ramırez-Tortosa MC, Mesa MD, Aguilera MC, Quiles JL, Baro L, Ramirez-Tortosa CL, Martinez-Victoria E, Gil A. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis. 1999 Dec 1;147(2):371-8.
Li X, Lu Y, Sun Y, Zhang Q. Effect of curcumin on permeability of coronary artery and expression of related proteins in rat coronary atherosclerosis heart disease model. Int J Clin Exp Pathol. 2015;8(6):7247.
Dikshit M, Rastogi L, Shukla R, Srimal RC. Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. Indian J Med Res. 1995 Jan 1;101:31-5.
Bengmark S, Mesa MD, Gil A. Plant-derived health-the effects of turmeric and curcuminoids. Nutr Hosp. 2009;24(3):273-81.
Jagetia GC, Aggarwal BB. “Spicing up” of the immune system by curcumin. J Clin Immunol. 2007 Jan;27:19-35.
Quiles JL, Aguilera C, Mesa MD, Ramirez‐Tortosa MC, Baro L, Gil A. An ethanolic‐aqueous extract of Curcuma longa decreases the susceptibility of liver microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits. Biofactors. 1998 Jan 1;8(1-2):79-85.
Cox FF, Misiou A, Vierkant A, Ale-Agha N, Grandoch M, Haendeler J, et al. Protective effects of curcumin in cardiovascular diseases—Impact on oxidative stress and mitochondria. Cells. 2022 Jan 20;11(3):342.
Coban D, Milenkovic D, Chanet A, Khallou‐Laschet J, Sabbe L, Palagani A, et al. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol Nutr Food Res. 2012 Aug;56(8):1270-81.
Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels. Saudi Med J. 2008;29(9):1280-4.
Mazidi M, Gao HK, Rezaie P, Ferns GA. The effect of ginger supplementation on serum C-reactive protein, lipid profile and glycaemia: a systematic review and meta-analysis. Food Nutr Res. 2016;60:32613.
Babaahmadi-Rezaei H. The effect of ginger supplementation on the lipid profile, blood glucose, quality of life and functional capacity in patients with coronary artery disease.
Sobenin IA, Pryanishnikov VV, Kunnova LM, Rabinovich YA, Martirosyan DM, Orekhov AN. The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease. Lipids Health Dis. 2010;9:1-6.
Kojuri J, Vosoughi AR, Akrami M. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis. 2007;6:1-5.
Valls RM, Companys J, Calderón-Pérez L, Salamanca P, Pla-Pagà L, Sandoval-Ramírez BA, et al. Effects of an optimized aged garlic extract on cardiovascular disease risk factors in moderate hypercholesterolemic subjects: a randomized, crossover, double-blind, sustained and controlled study. Nutrients. 2022 Jan;14(3):405.
Adab Z, Eghtesadi S, Vafa MR, Heydari I, Shojaii A, Haqqani H, Arablou T, et al. Effect of turmeric on glycemic status, lipid profile, hs‐CRP, and total antioxidant capacity in hyperlipidemic type 2 diabetes mellitus patients. Phytother Res. 2019 Apr;33(4):1173-81.
Pashine L, Singh JV, Vaish AK, Ojha SK, Mahdi AA. Effect of turmeric (Curcuma longa) on overweight hyperlipidemic subjects: Double-blind study. Indian J Community Health. 2012 Jun 30;24(2):113-7.
Jarhahzadeh M, Alavinejad P, Farsi F, Husain D, Rezazadeh A. The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double-blind clinical trial. Diabetol Metab Syndr. 2021;13:1-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Amna Muneer, Areej Iqbal Awan, Muhammad Hamza, Sami Ali Babekir, Waleed Fahad Alhujaili, Saliha Naeem, Fizza Saleem
This work is licensed under a Creative Commons Attribution 4.0 International License.
